• T-knife Therapeutics Announces Authorization of Clinical Trial Application for TK-6302, A Multi-Armored, CRISPR based T cell Therapy for Solid Tumors (09.03.2026)
  • 2026 “Jugend forscht” Berlin-Buch regional winners (06.03.2026)